The K ATP channel activator diazoxide ameliorates amyloid-β and Tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease

D Liu, M Pitta, JH Lee, B Ray, DK Lahiri… - Journal of …, 2010 - content.iospress.com
Compromised cellular energy metabolism, cerebral hypoperfusion, and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

[引用][C] The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease

D Liu, M Pitta, JH Lee, B Ray, DK Lahiri… - Journal of Alzheimer's …, 2010 - cir.nii.ac.jp
The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and
Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease | CiNii Research CiNii …

[PDF][PDF] The KATP Channel Activator Diazoxide Ameliorates Aβ and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease

D Liu, M Pitta, JH Lee, B Ray, D Lahiri, K Furukawa… - J Alzheimers …, 2010 - academia.edu
Compromised cellular energy metabolism, cerebral hypoperfusion and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

The K AT P Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease

D Liua, M Pittaa, JH Leea, B Rayc… - Journal of …, 2010 - content.iospress.com
Compromised cellular energy metabolism, cerebral hypoperfusion, and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease

D Liu, M Pitta, JH Lee, B Ray… - Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Compromised cellular energy metabolism, cerebral hypoperfusion, and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease.

D Liu, M Pitta, JH Lee, B Ray… - Journal of …, 2010 - search.ebscohost.com
Compromised cellular energy metabolism, cerebral hypoperfusion, and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

The KATP channel activator diazoxide ameliorates amyloid-β and Tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease

D Liu, M Pitta, JH Lee, B Ray… - Journal of …, 2010 - pure.johnshopkins.edu
Compromised cellular energy metabolism, cerebral hypoperfusion, and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

[HTML][HTML] The KATP Channel Activator Diazoxide Ameliorates Aβ and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease

D Liu, M Pitta, JH Lee, B Ray, D Lahiri… - Journal of Alzheimer's …, 2010 - ncbi.nlm.nih.gov
Compromised cellular energy metabolism, cerebral hypoperfusion and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.

D Liu, M Pitta, JH Lee, B Ray, DK Lahiri… - Journal of Alzheimer's …, 2010 - europepmc.org
Compromised cellular energy metabolism, cerebral hypoperfusion and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

[PDF][PDF] The KATP Channel Activator Diazoxide Ameliorates Aβ and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease

D Liu, M Pitta, JH Lee, B Ray, D Lahiri, K Furukawa… - J Alzheimers …, 2010 - academia.edu
Compromised cellular energy metabolism, cerebral hypoperfusion and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …